MediciNova, Inc. (MNOV) Financials

MNOV Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 40.4 million 3.2 million
March 31, 2026 42.7 million 3.3 million
Dec. 31, 2025 45.6 million 4.0 million
Sept. 30, 2025 47.6 million 3.6 million

MNOV Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -5.4 billion 584.1 million
March 31, 2026 -3.5 million 407761
Dec. 31, 2025 -2.0 million 338255
Sept. 30, 2025 -1.7 million 157692

MNOV Net Income

No data available :(

MNOV Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 25.4 million - 117038
March 31, 2026 27.3 million - 165198
Dec. 31, 2025 30.8 million - 194331
Sept. 30, 2025 32.6 million - 180751

MNOV Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 49.2 million
March 31, 2026 49.2 million
Dec. 31, 2025 49.1 million
Sept. 30, 2025 49.0 million

MNOV Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 10.8 million 1.0 million 1.8 million -
March 31, 2026 10827 1.3 billion 1.6 billion -
Dec. 31, 2025 2903 1.7 million 1.6 million -
Sept. 30, 2025 2903 1.5 million 1.8 million 48613

MNOV Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 458439 140680
March 31, 2026 186984 174361
Dec. 31, 2025 151739 99981
Sept. 30, 2025 123319 115272

MNOV

Price: $1.42

52 week price:
1.17
3.90

Earnings Per Share: -0.21 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 32551

Ebitda: -3.3 million

Market Capitalization: 87.6 million

Links: